Titan Biotech (524717.BO) Stock Price
Titan Biotech Price
Over the last 14 years Titan Biotech grew revenue by 17.1% annually, reaching 2.06 B INR. Earnings per share have grown at 24.1% per year over the last 14 years. For Titan Biotech, the net margin of 14.5% is down versus 17.6% a few years ago. At today's price the dividend yield works out to roughly 0.10%. The payout ratio is around 7% of earnings. The dividend has grown at 7.3% per year over the past 14 years.
Titan Biotech stock price
Titan Biotech business model & stock analysis
Frequently asked questions about Titan Biotech
Converted at the current exchange rate, the Titan Biotech share trades at 3.77 EUR (407.15 INR).
The revenue of Titan Biotech is 2.06 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Titan Biotech is 298.85 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Titan Biotech is currently 56.29. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Titan Biotech stock.
The price-to-sales ratio (P/S) of Titan Biotech is currently 8.16. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Titan Biotech stock.
The Eulerpool Quality Score for Titan Biotech is 7/10.
The ISIN of Titan Biotech is INE150C01029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Titan Biotech is 524717.BO. The ticker symbol is used to trade Titan Biotech shares on the stock exchange.
Titan Biotech stock
Titan Biotech Peer Group
Titan Biotech FIGI
All fundamentals and in-depth analysis of Titan Biotech
Our stock analysis for Titan Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Titan Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.